Charles River Laboratories International Share Price Today: Live Updates & Key Insights

Charles River Laboratories International share price today is $153.6, up 0.36%. The stock opened at $152.86 against the previous close of $153.05, with an intraday high of $155.4 and low of $150.825.

Charles River Laboratories International Share Price Chart

Charles River Laboratories International

us-stock
To Invest in {{usstockname}}
us-stock

Charles River Laboratories International Share Price Performance

$153.6 0.0036(0.36%) CRL at 23 Mar 2026 12:34 PM Diagnostics & Research
Lowest Today 150.825
Highest Today 155.4
Today’s Open 152.86
Prev. Close 153.05
52 Week High 228.88
52 Week Low 91.86
Day’s Range: Low 150.825 High 155.4
52-Week Range: Low 91.86 High 228.88
1 day return -
1 Week return +1.1
1 month return -6.1
3 month return -24.38
6 month return -0.16
1 year return -8.09
3 year return -21.95
5 year return -46.73
10 year return -

Charles River Laboratories International Institutional Holdings

Vanguard Group Inc 11.96

BlackRock Inc 7.83

Allspring Global Investments Holdings, LLC 4.05

State Street Corp 3.72

Wellington Management Company LLP 3.55

FMR Inc 3.52

Harris Associates L.P. 3.41

Allspring Mid Value SMA 3.24

Allspring Special US Mid Cap Value Eq 3.24

Vanguard Total Stock Mkt Idx Inv 3.16

Dimensional Fund Advisors, Inc. 2.93

Ariel Investments, LLC 2.90

Allspring Special Mid Cap Value Inst 2.87

Geode Capital Management, LLC 2.59

Vanguard 500 Index Investor 2.55

Amvescap Plc. 2.54

Bank of America Corp 2.36

Vanguard Small Cap Index 2.26

Oakmark Select Investor 2.04

Mackenzie Investments 2.02

Earnest Partners LLC 2.01

NATIONAL BANK OF CANADA /FI/ 1.92

Vanguard Windsor Investor Shares 1.88

Invesco Small Cap Value A 1.83

Massachusetts Financial Services Company 1.80

Invesco S&P 500® Equal Weight ETF 1.78

Neuberger Berman Group LLC 1.75

Arrowstreet Capital Limited Partnership 1.70

Morgan Stanley - Brokerage Accounts 1.70

Nomura Holdings Inc 1.64

Vanguard Small Cap Value Index Inv 1.45

Invesco Value Opportunities A 1.41

Invesco S&P 500 ETF 1.37

iShares Core S&P 500 ETF 1.27

Fidelity 500 Index 1.27

MFS Mid Cap Growth A 1.21

State Street® SPDR® S&P 500® ETF 1.19

Fidelity Contrafund 1.15

MFS Mid Cap Growth Equity 1.01

Ariel Fund Investor 1.00

Charles River Laboratories International Market Status

Strong Buy: 4

Buy: 0

Hold: 14

Sell: 0

Strong Sell: 1

Charles River Laboratories International Fundamentals

Market Cap 7561.39 M

PB Ratio 2.3893

PE Ratio 0.0

Enterprise Value 9918.03 M

Total Assets 7135.42 M

Volume 808601

Charles River Laboratories International Company Financials

Annual Revenue FY25:4015382000 4015.4M, FY24:4049989000 4050.0M, FY23:4215776000 4215.8M, FY22:3976060000 3976.1M, FY21:3540160000 3540.2M

Annual Profit FY25:1225573000 1225.6M, FY24:1331821000 1331.8M, FY23:1537355000 1537.4M, FY22:1462651000 1462.7M, FY21:1334638000 1334.6M

Annual Net worth FY25:-144338000 -144.3M, FY24:22203000 22.2M, FY23:474950000 475.0M, FY22:486226000 486.2M, FY21:390982000 391.0M

Quarterly Revenue Q4/2025:994227000 994.2M, Q3/2025:1004852000 1004.9M, Q2/2025:1032135000 1032.1M, Q1/2025:984168000 984.2M, Q4/2024:1002549000 1002.5M

Quarterly Profit Q4/2025:307855000 307.9M, Q3/2025:338792000 338.8M, Q2/2025:357067000 357.1M, Q1/2025:317732000 317.7M, Q4/2024:284244000 284.2M

Quarterly Net worth Q4/2025:-276555000 -276.6M, Q3/2025:54422000 54.4M, Q2/2025:52326000 52.3M, Q1/2025:25469000 25.5M, Q4/2024:-213747000 -213.7M

About Charles River Laboratories International & investment objective

Company Information Charles River Laboratories International, Inc. provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. The Research Models and Services segment produces and sells rodents, and purpose-bred rats and mice for use by researchers. This segment also provides a range of services to assist its clients in supporting the use of research models in research and screening pre-clinical drug candidates, including genetically engineered models and services, insourcing solutions, and research animal diagnostic services; and engages in development and production of cell therapies. The Discovery and Safety Assessment segment offers in vitro and in vivo discovery services for the discovery, development, and safety testing of novel drugs, molecule compounds, oligonucleotides, and biotherapeutics, and antibodies through delivery of preclinical drug and therapeutic candidates ready for safety assessment; safety assessment services, such as toxicology, pathology, safety pharmacology, bioanalysis, drug metabolism, and pharmacokinetics services; and vivarium space services. The Manufacturing Solutions segment provides in vitro methods for conventional and rapid quality control testing of sterile and non-sterile pharmaceuticals and consumer products; offers specialized testing of biologics that are outsourced by pharmaceutical and biotechnology companies; and contract development and manufacturing products and services. The company has strategic collaborations with Parker Institute for Cancer Immunotherapy and Children's Hospital Los Angeles across its contract development and manufacturing organization. Additionally, it has a strategic alliance with Francis Crick Institute (Crick), Inc. for the development of Antibody-Drug Conjugate (ADC) drug discovery and development. Charles River Laboratories International, Inc. was founded in 1947 and is headquartered in Wilmington, Massachusetts.

Organisation Diagnostics & Research

Employees 18300

Industry Diagnostics & Research

CEO Mr. James C. Foster J.D.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

Charles River Laboratories International FAQs

What is the share price of Charles River Laboratories International today?

The current share price of Charles River Laboratories International is $153.6.

Can I buy Charles River Laboratories International shares in India?

Yes, Indian investors can buy Charles River Laboratories International shares by opening an international trading and demat account with Motilal Oswal.

How to buy Charles River Laboratories International shares in India?

You can easily invest in Charles River Laboratories International shares from India by:

Can I buy fractional shares of Charles River Laboratories International?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Charles River Laboratories International?

Charles River Laboratories International has a market cap of $7561.39 M.

In which sector does Charles River Laboratories International belong?

Charles River Laboratories International operates in the Diagnostics & Research sector.

What documents are required to invest in Charles River Laboratories International stocks?

To invest, you typically need:

What is the PE and PB ratio of Charles River Laboratories International?

The PE ratio of Charles River Laboratories International is N/A and the PB ratio is 2.39.